Strategic alliance between Alma Bio Therapeutics and Delphi Genetics on Plasmid DNA drugs

Alma Bio Therapeutics SAS (Alma) and Delphi Genetics SA recently announced that they are taking their strategic alliance...

June 27, 2017 | Tuesday | News
J&J’s type 2 diabetes drug INVOKANA significantly reduces major heart complications in CANVAS program

Singapore – Results from the landmark CANVAS Program showed INVOKANA (canagliflozin) significantly reduc...

June 27, 2017 | Tuesday | News
BioAuxilium completes development of its 100th TR-FRET assay kit

Canada based company BioAuxilium specialised in the development of custom TR-FRET assay kit recently announced the succe...

June 23, 2017 | Friday | News
Major advancement in cell-based influenza vaccine technology by Seqirus

Innovator in influenza vaccines and pandemic preparedness Seqirus recently announced the next major advancement in the u...

June 23, 2017 | Friday | News
New patent issuance for Zyga's SImmetry Sacroiliac Joint Fusion System

Singapore - Zyga Technology, Inc., a US based medical device company announced the issuance of a new US Patent represent...

June 22, 2017 | Thursday | News
New antibody for effective blood cancer treatment using two-pronged approach

Singapore- Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells direct...

June 22, 2017 | Thursday | News
Sunless tan now a reality!

Scientists have answered the woes of spending hours and hours on sunbeds to achieve the perfect bronzed tone. Better yet...

June 21, 2017 | Wednesday | News
A type-2 diabetes drug found to reduce heart and kidney risk

Researchers have claimed that a drug that lowers blood sugar levels for people with Type 2 diabetes may also significant...

June 21, 2017 | Wednesday | News
Enzychem Lifesciences Announces Global Phase 2 Trial Inititation of EC-18 in Patients with Chemotherapy Induced Neutropenia(CIN)

Enzychem Lifesciences, Corp., a Korea based life sciences company announced the initiation of the dose-escalation stage ...

June 20, 2017 | Tuesday | News
NanoBio And Porton Biopharma receive approval to advance Anthrax Vaccine

NanoBio Corporation, a US based biopharmaceutical company focused on developing and commercializing vaccines and anti-in...

June 20, 2017 | Tuesday | News
New, long-acting insulin therapy demonstrates Cardiovascular Safety

Singapore - During a symposium, titled "Cardiovascular Safety of Insulin Degludec vs. Insulin Glargine in Patients with ...

June 13, 2017 | Tuesday | News
A translational research collaboration

The Scripps Research Institute (TSRI) and ShangPharma Innovation, Inc. (SPII) announced a strategic collaboration to acc...

June 9, 2017 | Friday | News
BD Receives FDA 510(K) Clearance for Molecular Test of Acute Gastroenteritis.

Singapore - BD (Becton, Dickinson and Company), a global medical technology company, announced 510 (k) clearance from th...

June 5, 2017 | Monday | News
Trends in Drug Discovery Outsourcing: A Perspective

Dr Subir Basak Chief Business Officer, GVK Biosciences Over the last two decades, the Pharmaceutical industry has seen ...

June 2, 2017 | Friday | Analysis
FDA approves new Novo Nordisk treatment for patients with Hemophilia

Singapore - Novo Nordisk, a US based global healthcare company announced that the U.S. Food and Drug Administration (FDA...

June 1, 2017 | Thursday | News
Biogen acquires Remedy Pharmaceuticals’ late stage drug CIRARA

Singapore: Remedy Pharmaceuticals, a privately-held pharmaceutical company focused on bringing life-saving treatments to...

May 23, 2017 | Tuesday | News
Symic Bio Secures $30 Million Series B financing 

Singapore: Symic Bio, a US based biopharmaceutical company announced the successful completion of a $30 million&nbs...

May 23, 2017 | Tuesday | News
Sanofi enters into a $273 mn research deal with Exscientia

Singapore: French drug giant Sanofi has inked a $273 million research deal and licence option agreement in metabolic dis...

May 10, 2017 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls